Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

A Mixed Monday For Asian Equities

Published 05/03/2021, 04:34 AM

Asia markets cautious in holiday-thinned trade

Friday’s price action on Wall Street was somewhat jumbled amid month-end rebalancing flows by institutional investors and taper-talk from Fed Governor Robert Kaplan. On Friday, Kaplan said that there are excesses and imbalances in financial markets and the Fed needs to start discussing tapering.

The S&P 500 fell 0.72%, while the NASDAQ fell 0.85%, with the Dow Jones retesting 0.53%. That left the major indices flat to slightly lower for the week, even as they recorded solid monthly gains.

If anything, the price action suggests that investors are nervous at these heady levels and hyper-sensitive to any tapering headlines, no matter who makes them. Equities are not the only asset class to be behaving that way to be fair, as we shall see.

US index futures have risen by between 0.20% and 0.30% in Asia, but that hasn’t lifted sentiment in holiday-thinned markets, nor has the robust PMI data. One exception is Hong Kong was 1.40% lower. The source of its woes appears to be a continuing stream of negative headline regarding the mainland Government and China big-tech companies, many of which are listed in Hong Kong.

Singapore was also suffering as investors took fright at widening community cases in its latest COVID-19 outbreaks. The government signaled over the weekend that it was preparing to reimpose restrictions if the outbreak increases. The STI has fallen 1.40% today as investors fear the impact on the City-state’s fragile domestic recovery.

Elsewhere, Kuala Lumpur and Jakarta were 0.35% lower, Taipei has fallen 1.50% on localized COVID-19 fears as well. At the same time, South Korea’s KOSPI, and Australia’s All Ordinaries and ASX 200 were all unchanged for the day.

Looking at the COVID-19 reactions around Asia, it is hard to see India’s Sensex rallying later today. European markets should remain relatively immune, though, with PMI data likely to support modest gains.

Original Post

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.